{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,6]],"date-time":"2026-01-06T13:59:11Z","timestamp":1767707951772},"reference-count":32,"publisher":"Japanese Society of Internal Medicine","issue":"12","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2021,6,15]]},"DOI":"10.2169\/internalmedicine.6168-20","type":"journal-article","created":{"date-parts":[[2021,1,31]],"date-time":"2021-01-31T22:06:20Z","timestamp":1612130780000},"page":"1949-1953","source":"Crossref","is-referenced-by-count":4,"title":["Sporadic Amyotrophic Lateral Sclerosis Due to a FUS P525L Mutation with Asymmetric Muscle Weakness and Anti-ganglioside Antibodies"],"prefix":"10.2169","volume":"60","author":[{"given":"Masanobu","family":"Tanemoto","sequence":"first","affiliation":[{"name":"Department of Neurology, Sapporo Medical University, School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shin","family":"Hisahara","sequence":"additional","affiliation":[{"name":"Department of Neurology, Sapporo Medical University, School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuna","family":"Ikeda","sequence":"additional","affiliation":[{"name":"Department of Neurology, Sapporo Medical University, School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuki","family":"Yokokawa","sequence":"additional","affiliation":[{"name":"Department of Neurology, Sapporo Medical University, School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tatsuo","family":"Manabe","sequence":"additional","affiliation":[{"name":"Department of Neurology, Sapporo Medical University, School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Reiko","family":"Tsuda","sequence":"additional","affiliation":[{"name":"Department of Neurology, Sapporo Medical University, School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daisuke","family":"Yamamoto","sequence":"additional","affiliation":[{"name":"Department of Neurology, Sapporo Medical University, School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takashi","family":"Matsushita","sequence":"additional","affiliation":[{"name":"Department of Neurology, Sapporo Medical University, School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akihiro","family":"Matsumura","sequence":"additional","affiliation":[{"name":"Department of Neurology, Sapporo Medical University, School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Syuuichirou","family":"Suzuki","sequence":"additional","affiliation":[{"name":"Department of Neurology, Sapporo Medical University, School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shun","family":"Shimohama","sequence":"additional","affiliation":[{"name":"Department of Neurology, Sapporo Medical University, School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"962","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Lattante S, Rouleau GA, Kabashi E. TARDBP and FUS mutations associated with amyotrophic lateral sclerosis: summary and update. Hum Mutat 34: 812-826, 2013.","DOI":"10.1002\/humu.22319"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Join task force of the EFNS and the PNS. European federation of neurological societies\/peripheral nerve society guideline on management of multifocal motor neuropathy. Report of a joint task force of the European federation of neurological societies and peripheral nerve society-first revision.. J Peripher Nerv Syst 15: 295-301, 2010.","DOI":"10.1111\/j.1529-8027.2010.00290.x"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Pakiam ASI, Parry GJ. Multifocal motor neuropathy without overt conduction block. Muscle Nerve 21: 243-245, 1998.","DOI":"10.1002\/(SICI)1097-4598(199802)21:2<243::AID-MUS14>3.0.CO;2-2"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Cats EA, van der Pol WL, Piepers S, et al. Correlates of outcome and response to IVIg in 88 patients with multifocal motor neuropathy. Neurology 75: 818-825, 2010.","DOI":"10.1212\/WNL.0b013e3181f0738e"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Kusunoki S, Chiba A, Kon K, et al. N-acetylgalactosaminyl GD1a is a target molecule for serum antibody in Guillain-Barr\u00e9 syndrome. Ann Neurol 35: 570-576, 1994.","DOI":"10.1002\/ana.410350510"},{"key":"6","doi-asserted-by":"publisher","unstructured":"6. Kaida K, Kusunoki S, Kamakura K, Motoyoshi K, Kanazawa I. Guillain-Barr\u00e9 syndrome with antibody to a ganglioside, N-acetylgalactosaminyl GD1a. Brain 123: 116-124, 2000.","DOI":"10.1093\/brain\/123.1.116"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Li D, Usuki S, Quarles B, Rivner MH, Ariga T, Yu RK. Anti-sulfoglucuronosyl paragloboside antibody: a potential serologic marker of amyotrophic lateral sclerosis. ASN Neuro 8: 1759091416669619, 2016.","DOI":"10.1177\/1759091416669619"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Lai SL, Abramzon Y, Schymick JC, et al. FUS mutations in sporadic amyotrophic lateral sclerosis. Neurobiol Aging 32: 550 (e1-4), 2011.","DOI":"10.1016\/j.neurobiolaging.2009.12.020"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Zhou B, Wang H, Cai Y, et al. FUS P525L mutation causing amyotrophic lateral sclerosis and movement disorders. Brain Behav 10: e01625, 2020.","DOI":"10.1002\/brb3.1625"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Wanleenuwat P, Iwanowski P, Kozubski W. Antiganglioside antibodies in neurological diseases. J Neurol Sci 408: 116576, 2020.","DOI":"10.1016\/j.jns.2019.116576"},{"key":"11","doi-asserted-by":"publisher","unstructured":"11. Kaida K, Ariga T, Yu RK. Antiganglioside antibodies and their pathophysiological effects on Guillain-Barr\u00e9 syndrome and related disorders-a review. Glycobiology 19: 676-692, 2009.","DOI":"10.1093\/glycob\/cwp027"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Antoine JC, Camdessanch\u00e9 JP, Ferraud K, Caudie C. Antiganglioside antibodies in paraneoplastic peripheral neuropathies. J Neurol Neurosurg Psychiatry 75: 1765-1767, 2004.","DOI":"10.1136\/jnnp.2003.032193"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Kaji R, Kusunoki S, Mizutani K, et al. Chronic motor axonal neuropathy associated with antibodies monospecific for N-acetylgalactosaminyl GD1a. Muscle Nerve 23: 702-706, 2000.","DOI":"10.1002\/(SICI)1097-4598(200005)23:5<702::AID-MUS6>3.0.CO;2-A"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Ogawa-Goto K, Funamoto N, Ohta Y, Abe T, Nagashima K. Myelin gangliosides of human peripheral nervous system: an enrichment of GM1 in the motor nerve myelin isolated from cauda equina. J Neurochem 59: 1844-1849, 1992.","DOI":"10.1111\/j.1471-4159.1992.tb11018.x"},{"key":"15","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1212\/01.WNL.0000081229.88862.C6","volume":"61","author":"K Kaida","year":"2003","unstructured":"15. Kaida K, Kusunoki S, Kamakura K, Motoyoshi K, Kanazawa I. GalNAc-GD1a in human peripheral nerve: target sites of anti-ganglioside antibody. Neurology 61: 465-470, 2003.","journal-title":"Neurology","ISSN":"http:\/\/id.crossref.org\/issn\/0028-3878","issn-type":"print"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Ariga T. Pathogenic role of ganglioside metabolism in neurodegenerative diseases. J Neurosci Res 92: 1227-1242, 2014.","DOI":"10.1002\/jnr.23411"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Yamazaki T, Suzuki M, Irie T, Watanabe T, Mikami H, Ono S. Amyotrophic lateral sclerosis associated with IgG anti-GalNAc-GD1a antibodies. Clin Neurol Neurosurg 110: 722-724, 2008.","DOI":"10.1016\/j.clineuro.2008.03.010"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Tateishi T, Hokonohara T, Yamasaki R, et al. Multiple system degeneration with basophilic inclusions in Japanese ALS patients with FUS mutation. Acta Neuropathol 119: 355-364, 2010.","DOI":"10.1007\/s00401-009-0621-1"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Akiyama T, Warita H, Kato M, et al. Genotype-phenotype relationships in familial amyotrophic lateral sclerosis with FUS\/TLS mutations in Japan. Muscle Nerve 54: 398-404, 2016.","DOI":"10.1002\/mus.25061"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Groen EJ, van Es MA, van Vught PW, et al. FUS mutations in familial amyotrophic lateral sclerosis in the Netherlands. Arch Neurol 67: 224-230, 2010.","DOI":"10.1001\/archneurol.2009.329"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Vucic S, Ziemann U, Eisen A, Hallett M, Kiernan MC. Transcranial magnetic stimulation and amyotrophic lateral sclerosis: pathophysiological insights. J Neurol Neurosurg Psychiatry 84: 1161-1170, 2013.","DOI":"10.1136\/jnnp-2012-304019"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Gu\u00e9gan C, Vila M, Rosoklija G, Hays AP, Przedborski S. Recruitment of the mitochondrial-dependent apoptotic pathway in amyotrophic lateral sclerosis. J Neurosci 21: 6569-6576, 2001.","DOI":"10.1523\/JNEUROSCI.21-17-06569.2001"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Kollewe K, Wurster U, Sinzenich T, et al. Anti-ganglioside antibodies in amyotrophic lateral sclerosis revisited. PLoS ONE 10: e0125339, 2015.","DOI":"10.1371\/journal.pone.0125339"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Lobsiger CS, Boill\u00e9e S, Cleveland DW. Toxicity from different SOD1 mutants dysregulates the complement system and the neuronal regenerative response in ALS motor neurons. Proc Natl Acad Sci USA 104: 7319-7326, 2007.","DOI":"10.1073\/pnas.0702230104"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25. Baker DJ, Blackburn DJ, Keatinge M, et al. Lysosomal and phagocytic activity is increased in astrocytes during disease progression in the SOD1 (G93A) mouse model of amyotrophic lateral sclerosis. Front Cell Neurosci 9: 410, 2015.","DOI":"10.3389\/fncel.2015.00410"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26. Dodge JC, Treleaven CM, Pacheco J, et al. Glycosphingolipids are modulators of disease pathogenesis in amyotrophic lateral sclerosis. Proc Natl Acad Sci USA 112: 8100-8105, 2015.","DOI":"10.1073\/pnas.1508767112"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27. Huang EJ, Zhang J, Geser F, et al. Extensive FUS-immunoreactive pathology in juvenile amyotrophic lateral sclerosis with basophilic inclusions. Brain Pathol 20: 1069-1076, 2010.","DOI":"10.1111\/j.1750-3639.2010.00413.x"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28. Mochizuki Y, Isozaki E, Takao M, et al. Familial ALS with FUS P525L mutation: two Japanese sisters with multiple systems involvement. J Neurol Sci 323: 85-92, 2012.","DOI":"10.1016\/j.jns.2012.08.016"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29. Leblond CS, Webber A, Gan-Or Z, et al. De novo FUS P525L mutation in juvenile amyotrophic lateral sclerosis with dysphonia and diplopia. Neurol Genet 2: e63, 2016.","DOI":"10.1212\/NXG.0000000000000063"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30. Eura N, Sugie K, Suzuki N, et al. A juvenile sporadic amyotrophic lateral sclerosis case with P525L mutation in the FUS gene: a rare co-occurrence of autism spectrum disorder and tremor. J Neurol Sci 398: 67-68, 2019.","DOI":"10.1016\/j.jns.2019.01.032"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31. B\u00e4umer D, Hilton D, Paine SML, et al. Jevenile ALS with basophilic inclusions is a FUS proteinopathy with FUS mutations. Neurology 75: 611-618, 2010.","DOI":"10.1212\/WNL.0b013e3181ed9cde"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32. Yamashita S, Mori A, Sakaguchi H, et al. Sporadic juvenile amyotrophic lateral sclerosis caused by mutant FUS\/TLS: possible association of mental retardation with this mutation. J Neurol 259: 1039-1044, 2012.","DOI":"10.1007\/s00415-011-6292-6"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/60\/12\/60_6168-20\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,19]],"date-time":"2021-06-19T03:32:23Z","timestamp":1624073543000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/60\/12\/60_6168-20\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6,15]]},"references-count":32,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.6168-20","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,6,15]]}}}